Corvus Pharmaceuticals announced the publication of preclinical data on soquelitinib, its lead ITK inhibitor, highlighting its potential in modulating tumor immunity. The publication details its mechanism of action and potential applications in oncology and immune diseases.
Company Information
Company
Corvus Pharmaceuticals, Inc.
Location
California, United States
About
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company
Fundz sees it the moment Corvus Pharmaceuticals, Inc. ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CaliforniaBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma